+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
PFIZER
₹4,898.50 +20.9 (0.43%)

11 Aug, 2026 3:54 PM (IST)

Pfizer live price: ₹4,898.50. It opened at ₹4,878 vs previous close ₹4,878; intraday high/low: ₹4,913/₹4,840. The 50 & 200 DMA stand at ₹4,701.00/₹4,791.60.

Pfizer Performance

  • Today's Low
  • ₹4,840
  • Today's High
  • ₹4,913
  • 52 Week Low
  • ₹4,360
  • 52 Week High
  • ₹5,874
  • Open Price₹4,878
  • Previous Close₹4,878
  • Volume32,191
  • 50 DMA₹4,701.00
  • 100 DMA₹4,715.30
  • 200 DMA₹4,791.60

Pfizer Chart

Investment Returns

  • Over 1 Month + 3.53%
  • Over 3 Month + 1.65%
  • Over 6 Month -1.26%
  • Over 1 Year -1.89%

Smart Investing Starts Here Start SIP with Pfizer for Steady Growth!

Invest Now

Pfizer Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 30.5
  • PEG Ratio
  • -3.4
  • Market Cap Cr
  • 22,410
  • P/B Ratio
  • 5.3
  • Average True Range
  • 95.1
  • EPS
  • 160.7
  • Dividend Yield
  • 1.5
  • MACD Signal
  • 81.6
  • RSI
  • 65.6
  • MFI
  • 78.47

Latest Stock News Updates

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

On an adjusted basis, the company reported a profit of 77 cents per share

Pfizer Ltd - 500680 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advertisement - Special Window for Re- lodgement of Transfer and Dematerialisation of Physical Securities.

Pfizer Ltd - 500680 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Pursuant to Regulation 44 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, we submit herewith the consolidated Scrutinizer''s Report of the votes cast through remote e-voting and electronic polling process conducted during the 75th Annual General Meeting of the Company held on Tuesday, July 28, 2026, at 3.00 p.m. IST.

Pfizer Financials

Pfizer Technicals

EMA & SMA

Current Price
₹4,898.50
+ 20.9 (0.43%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹4,780.10
  • 50 Day
  • ₹4,701.00
  • 100 Day
  • ₹4,715.30
  • 200 Day
  • ₹4,791.60

Resistance and Support

4883.87 Pivot Speed
  • R3 5,000.80
  • R2 4,957.00
  • R1 4,927.70
  • S1 4,854.60
  • S2 4,810.80
  • S3 4,781.50

Pfizer Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-28 Quarterly Results
2026-05-12 Audited Results & Final Dividend
2026-02-09 Quarterly Results
2025-11-12 Quarterly Results
2025-08-13 Quarterly Results
Date Purpose Remarks
2026-07-17 FINAL Rs.75.00 per share(750%)Final Dividend
2025-07-09 SPECIAL Rs.130.00 per share(1300%)Special Dividend
2025-07-09 FINAL Rs.35.00 per share(350%)Final Dividend
2024-08-21 FINAL Rs.35.00 per share(350%)Final Dividend
2023-08-11 SPECIAL Rs.5.00 per share(50%)Special Dividend
View Pfizer Dividend History Arrow

Pfizer Shareholding Pattern

63.92%
16.62%
12.68%
5.12%
1.65%

About Pfizer

Pfizer is engaged in manufacturing, marketing, distribution and trading of pharmaceutical products. The Company has its own manufacturing facility at Goa. The Company has various independent contract / third party manufacturers based across the country. The Company sells its products primarily in India through independent distributors. View More
  • NSE Symbol
  • PFIZER
  • BSE Symbol
  • 500680
  • Executive Director,Managing Director,Chief Executive Officer
  • Meenakshi Nevatia
  • ISIN
  • INE182A01018

Similar Stocks to Pfizer

Pfizer FAQs

Pfizer share price is ₹4,898 As on 12 August, 2026 | 00:55

The Market Cap of Pfizer is ₹22409.5 Cr As on 12 August, 2026 | 00:55

The P/E ratio of Pfizer is 30.5 As on 12 August, 2026 | 00:55

The PB ratio of Pfizer is 5.3 As on 12 August, 2026 | 00:55

The 52 week High & Low of Pfizer is ₹5873.5/₹4360.1 respectively As on 12 August, 2026 | 00:55

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23